Related Experiment Video
Updated: Dec 11, 2025
06:35
A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
4.9K
Anti-Metastasis Fascin Inhibitors Decrease the Growth of Specific Subtypes of Cancers.
Yufeng Wang1, J Jillian Zhang2, Xin-Yun Huang1,3
1Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA.
Cancers
|August 23, 2020
Summary
Small-molecule fascin inhibitors show promise in preventing tumor metastasis and decreasing the growth of specific cancers like triple-negative breast cancer and diffuse large B-cell lymphoma.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Fascin is an actin-bundling protein crucial for cytoskeletal structures.
- Elevated fascin expression in tumors correlates with poor patient survival.
- Fascin drives tumor cell migration, invasion, and metastasis.
Purpose of the Study:
- To characterize novel small-molecule fascin inhibitors.
- To evaluate their efficacy in preventing tumor metastasis.
- To assess their impact on the growth of specific cancer subtypes.
Main Methods:
- Development and characterization of small-molecule fascin inhibitors.
- In vivo studies in mice to assess anti-metastatic effects.
- Evaluation of inhibitor efficacy against specific cancer subtypes, including EGFR-high triple-negative breast cancer and activated B-cell diffuse large B-cell lymphoma.
Main Results:
- Fascin inhibitors demonstrated efficacy in preventing tumor metastasis in mice.
- These inhibitors also decreased tumor growth in EGFR-high triple-negative breast cancer.
- Fascin inhibitors reduced tumor growth in activated B-cell subtype diffuse large B-cell lymphoma.
Conclusions:
- Small-molecule fascin inhibitors are effective against tumor metastasis.
- Fascin inhibitors represent a potential therapeutic strategy for specific cancer types, including certain breast and lymphoma subtypes.
- Targeting fascin offers a dual approach to combat cancer by inhibiting metastasis and reducing tumor growth.
More Related Videos
09:17Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
7.1K
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
696
Related Concept Videos
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:15Drugs that Stabilize Microtubules
2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
02:38Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
01:35Cancer Cell Migration through Invadopodia
3.0K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K
01:10Drugs that Destabilize Microtubules
3.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.3K
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K